News

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...
Here are seven potentially kidney-harming habits to avoid: ...
Five members of the Lose It! weight loss app community gathered in New York City for a nutritious breakfast — and shared ...
Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...
In the UK, more than 10% of the population is estimated to have some stage of chronic kidney disease and more than 600,000 ...
Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...
Emotional eating and body dissatisfaction mediate links between BMI changes and mental health. These psychosocial factors ...
The Mediterranean diet has tons of benefits. Find out why the Mediterranean diet may be especially good as you age.
Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, ...
A study found that daily avocado consumption of about one whole, medium avocado per day improves the gut microbiome. Avocado ...
As a specialty registrar in paediatric dentistry, I’ve seen first-hand the pain children experience because of poor oral ...
BENGALURU: Over half of Karnataka’s population screened in 2024 was either obese or overweight, with 56% diagnosed as obese ...